Prospera Financial Services’s ARK Genomic Revolution ETF ARKG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.31M Buy
31,189
+57
+0.2% +$1.81K 0.02% 661
2026
Q1
$823K Buy
31,132
+762
+3% +$22.3K 0.01% 799
2025
Q4
$880K Sell
30,370
-929
-3% -$27.9K 0.01% 722
2025
Q3
$869K Sell
31,299
-4,552
-13% -$115K 0.01% 732
2025
Q2
$873K Sell
35,851
-1,110
-3% -$24.3K 0.02% 705
2025
Q1
$767K Buy
36,961
+1,253
+4% +$31.5K 0.02% 637
2024
Q4
$841K Buy
35,708
+2,101
+6% +$51.7K 0.02% 593
2024
Q3
$860K Buy
33,607
+5,180
+18% +$132K 0.02% 539
2024
Q2
$667K Buy
28,427
+10,556
+59% +$266K 0.02% 612
2024
Q1
$514K Buy
17,871
+5,734
+47% +$172K 0.02% 707
2023
Q4
$398K Buy
+12,137
New +$330K 0.01% 729
2023
Q2
Sell
-8,644
Closed -$260K 1012
2023
Q1
$260K Sell
8,644
-465
-5% -$14.4K 0.01% 825
2022
Q4
$257K Buy
9,109
+2,337
+35% +$74.2K 0.01% 761
2022
Q3
$222K Sell
6,772
-110
-2% -$4.04K 0.01% 747
2022
Q2
$217K Sell
6,882
-1,406
-17% -$49.2K 0.01% 712
2022
Q1
$381K Buy
8,288
+1,208
+17% +$57.6K 0.02% 674
2021
Q4
$434K Sell
7,080
-128
-2% -$8.85K 0.02% 610
2021
Q3
$539K Buy
7,208
+980
+16% +$82.2K 0.03% 512
2021
Q2
$576K Buy
6,228
+2,712
+77% +$231K 0.03% 495
2021
Q1
$312K Buy
+3,516
New +$349K 0.02% 606
2020
Q4
Sell
-200
Closed -$13K 728
2020
Q3
$13K Buy
+200
New +$11.7K 0.01% 1024

Other funds holding ARKG

Prospera Financial Services's ARKG Position: Q2 2026 in Review

Prospera Financial Services increased its ARK Genomic Revolution ETF (ARKG) stake by 0.18% in Q2 2026, buying an estimated $1.81K and bringing the position to 31,189 shares worth $1.31M. The position accounts for 0.02% of the portfolio, ranked #661.

Prospera Financial Services first reported a position in ARKG in Q3 2020 and has held it in 21 quarters since. 271 funds tracked by Wall St. Rank hold ARKG as of Q2 2026.

  • Prospera Financial Services held 31,189 shares of ARK Genomic Revolution ETF worth $1.31M as of Q2 2026.
  • Prospera Financial Services bought 57 ARK Genomic Revolution ETF shares in Q2 2026, an estimated $1.81K.
  • ARK Genomic Revolution ETF made up 0.02% of Prospera Financial Services's portfolio in Q2 2026, its #661 holding.
  • Prospera Financial Services first reported a position in ARK Genomic Revolution ETF in Q3 2020 and has held it in 21 quarters since.
  • 271 funds tracked by Wall St. Rank held ARK Genomic Revolution ETF as of Q2 2026.

Based on Prospera Financial Services's 13F filing for Q2 2026, filed 15 Jul 2026.